NASDAQ: IRIX - IRIDEX Corporation

六个月盈利: -16.92%
部门: Healthcare

促销时间表 IRIDEX Corporation


关于公司

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

更多详情
It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IPO date 1996-02-15
ISIN US4626841013
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.iridex.com
Цена ао 2.51
每日价格变化: 0% (1.67)
每周价格变化: +1.83% (1.64)
每月价格变化: -7.22% (1.8)
3个月内价格变化: -6.7% (1.79)
六个月内的价格变化: -16.92% (2.01)
每年价格变化: -40.57% (2.81)
3年内价格变化: -70.49% (5.66)
5年内价格变化: -29.24% (2.36)
10年价格变化: 0% (1.67)
年初以来价格变化: -12.27% (1.9035)

低估

姓名 意义 年级
P/S 0.8084 9
P/BV 4.4 4
P/E 0 0
EV/EBITDA -4.72 0
全部的: 5.13

效率

姓名 意义 年级
ROA, % -27.79 0
ROE, % -100.5 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.3443 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 19.51 3
盈利能力 Ebitda, % -11.39 0
盈利能力 EPS, % -7.72 0
全部的: 1

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.00705 17.09 1.54048
Dimensional U.S. Core Equity 2 ETF 0.00005 30.76 1.47098



导师 职称 支付 出生年份
Mr. David I. Bruce CEO & Director 397.19k 1959 (66 年)
Mr. Fuad Ahmad Interim Chief Financial Officer 356.83k 1970 (55 年)
Mr. Patrick Mercer President & COO 365.85k 1972 (53 年)
Ms. Leigh Salvo Head of Investor Relations N/A

地址: United States, Mountain View. CA, 1212 Terra Bella Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.iridex.com